Genetic susceptibility on caga-interacting molecules and gene-environment interaction with phytoestrogens: A putative risk factor for gastric cancer

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Yang, Jae Jeong ^a,b   Cho, Lisa Y ^a,b   Ko, Kwang Pil ^c   Shin, Aesun ^d   Ma, Seung Hyun ^a,b   Choi, Bo Youl ^e   Han, Dong Soo ^e   Song, Kyu Sang ^f   Kim, Yong Sung ^g   Lee, Jong Young ^h   Han, Bok Ghee ^h   Chang, Soung Hoon ⁱ   Shin, Hai Rim ^d,j   Kang, Daehee ^a,b   Yoo, Keun Young ^a   Park, Sue K ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Gachon University College of Medicine   (South Korea)

^d National Cancer Center   (South Korea)

^e Hanyang University College of Medicine   (South Korea)

^f Chungnam National University College of Medicine   (South Korea)

^g Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^h Korea National Institute of Health   (South Korea)

ⁱ Konkuk University   (South Korea)

^j WORLD HEALTH ORGANIZATION   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; ENTEROLACTONE; EQUOL; GENISTEIN; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI; CRK PROTEIN, HUMAN; ONCOPROTEIN; PHYTOESTROGEN; PROTEIN TYROSINE KINASE; SCATTER FACTOR RECEPTOR;

ARTICLE; BACTERIAL STRAIN; C MET GENE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; CRK GENE; CRKL GENE; CSK GENE; ESTROGEN BLOOD LEVEL; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; GRB2 GENE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PTPN11 GENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SRC GENE; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR GENE; BIOLOGICAL MODEL; CASE CONTROL STUDY; FLUORESCENCE MICROSCOPY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; IMMUNOASSAY; METABOLISM; METHODOLOGY; MICROBIOLOGY; RISK; STOMACH TUMOR;

HELICOBACTER PYLORI;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; COHORT STUDIES; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOASSAY; MICROSCOPY, FLUORESCENCE; MODELS, GENETIC; ODDS RATIO; PHYTOESTROGENS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-CRK; PROTO-ONCOGENE PROTEINS C-MET; RISK; SRC-FAMILY KINASES; STOMACH NEOPLASMS;

EID: 84863157455     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031020     Document Type: Article

References (50)

1. International Agency for Research on Cancer (IARC) (1994) IARC Monographs on the evaluation of carcinogenic risks to human: Schistosomes, liver flukes and Helicobacter pylori Lyon, France IARC Press pp. 177-240.
2. Blaser MJ, (1998) Helicobacter pylori and gastric diseases. BMJ 316: 1507-1510.
3. Hatakeyama M, Higashi H, (2005) Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci 96: 835-843.
4. Gwack J, Shin A, Kim CS, Ko KP, Kim Y, et al. (2006) CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case-control study in Korea. Br J Cancer 95: 639-641.
5. Shin A, Shin HR, Kang D, Park SK, CS K, et al. (2005) A nested case-control study of the association of Helicobacter pylori infection with gastric adenocarcinoma in Korea. Br J Cancer 92: 1273-1275.
6. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, et al. (1995) Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55: 2111-2115.
7. Parsonnet J, Friedman GD, Orentreich N, Vogelman H, (1997) Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40: 297-301.
8. Hatakeyama M, (2006) The role of Helicobacter pylori CagA in gastric carcinogenesis. Int J Hematol 84: 301-308.
9. Fischer W, Püls J, Buhrdorf R, Gebert B, Odenbreit S, et al. (2001) Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol 42: 1337-1348.
10. Rohde M, Püls J, Buhrdorf R, Fischer W, Haas R, (2003) A novel sheathed surface organelle of the Helicobacter pylori cag type IV secretion system. Mol Microbiol 49: 219-234.
11. Handa O, Naito Y, Yoshikawa T, (2007) CagA protein of Helicobacter pylori: a hijacker of gastric epithelial cell signaling. Biochem Pharmacol 73: 1697-1702.
12. Wen S, Moss SF, (2009) Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett 282: 1-8.
13. Selbach M, Moese S, Hauck CR, Meyer TF, Backert S, (2002) Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem 277: 6775-6778.
14. Suzuki M, Mimuro H, Suzuki T, Park M, Yamamoto T, et al. (2005) Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. J Exp Med 202: 1235-1247.
15. Tsutsumi R, Higashi H, Higuchi M, Okada M, Hatakeyama M, (2003) Attenuation of Helicobacter pylori CagA x SHP-2 signaling by interaction between CagA and C-terminal Src kinase. J Biol Chem 278: 3664-3670.
16. Ando T, Goto Y, Ishiguro K, Maeda O, Watanabe O, et al. (2007) The interaction of host genetic factors and Helicobacter pylori infection. Inflammopharmacology 15: 10-14.
17. Gentile A, Trusolino L, Comoglio PM, (2008) The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev 27: 85-94.
18. Hatakeyama M, (2004) Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 4: 688-694.
19. Porter J, (2010) Small molecule c-Met kinase inhibitors: a review of recent patents. Expert Opin Ther Pat 20: 159-177.
20. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, et al. (1993) Genistein arrests cell cycle progression at G2-M. Cancer Res 53: 1328-1331.
21. Zhou HB, Chen JJ, Wang WX, Cai JT, Du Q, (2004) Apoptosis of human primary gastric carcinoma cells induced by genistein. World J Gastroenterol 10: 1822-1825.
22. Hong H, Landauer MR, Foriska MA, Ledney GD, (2006) Antibacterial activity of the soy isoflavone genistein. J Basic Microbiol 46: 329-335.
23. Odenbreit S, Püls J, Sedlmaier B, Gerland E, Fischer W, et al. (2000) Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287: 1497-1500.
24. Yoo KY, Shin HR, Chang SH, Lee KS, Park SK, et al. (2002) Korean Multi-center Cancer Cohort Study including a Biological Materials Bank (KMCC-I). Asian Pac J Cancer Prev 3: 85-92.
25. Cho LY, Kim CS, Li L, Yang JJ, Park B, et al. (2009) Validation of self-reported cancer incidence at follow-up in a prospective cohort study. Ann Epidemiol 19: 644-646.
26. Lin CH, Yeakley JM, McDaniel TK, Shen R, (2009) Medium- to high-throughput SNP genotyping using VeraCode microbeads. Methods Mol Biol 496: 129-142.
27. Park CY, Cho YK, Kodama T, El-Zimaity HM, Osato MS, et al. (2002) New serological assay for detection of putative Helicobacter pylori virulence factors. J Clin Microbiol 40: 4753-4756.
28. Ko KP, Park SK, Park B, Yang JJ, Cho LY, et al. (2010) Isoflavones from phytoestrogens and gastric cancer risk: a nested case-control study within the Korean Multicenter Cancer Cohort. Cancer Epidemiol Biomarkers Prev 19: 1292-1300.
29. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 57: 289-300.
30. Hardy RJ, Thompson SG, (1998) Detecting and describing heterogeneity in meta-analysis. Stat Med 17: 841-856.
31. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
32. Summy JM, Gallick GE, (2003) Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 22: 337-358.
33. Ma PC, Tretiakova MS, MacKinnon AC, Ramnath N, Johnson C, et al. (2008) Expression and mutational analysis of MET in human solid cancers. Genes Chromosomes Cancer 47: 1025-1037.
34. Inoue T, Kataoka H, Goto K, Nagaike K, Igami K, et al. (2004) Activation of c-Met (hepatocyte growth factor receptor) in human gastric cancer tissue. Cancer Sci 95: 803-808.
35. Takeuchi H, Bilchik A, Saha S, Turner R, Wiese D, et al. (2003) c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. Clin Cancer Res 9: 1480-1488.
36. Kuniyasu H, Yasui W, Kitadai Y, Yokozaki H, Ito H, et al. (1992) Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun 189: 227-232.
37. Gual P, Giordano S, Williams TA, Rocchi S, Van Obberghen E, et al. (2000) Sustained recruitment of phospholipase C-gamma to Gab1 is required for HGF-induced branching tubulogenesis. Oncogene 19: 1509-1518.
38. Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK, Wong AJ, (1996) A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379: 560-564.
39. Hatakeyama M, (2003) Helicobacter pylori CagA- a potential bacterial oncoprotein that functionally mimics the mammalian Gab family of adaptor proteins. Microbes Infect 5: 143-150.
40. Kobashigawa Y, Sakai M, Naito M, Yokochi M, Kumeta H, et al. (2007) Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK. Nat Struct Mol Biol 14: 503-510.
41. Birge RB, Kalodimos C, Inagaki F, Tanaka S, (2009) Crk and CrkL adaptor proteins: networks for physiological and pathological signaling. Cell Commun Signal 7.
42. Nishihara H, Tanaka S, Tsuda M, Oikawa S, Maeda M, et al. (2002) Molecular and immunohistochemical analysis of signaling adaptor protein Crk in human cancers. Cancer Lett 180: 55-61.
43. Miller CT, Chen G, Gharib TG, Wang H, Thomas DG, et al. (2003) Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas. Oncogene 22: 7950-7957.
44. Chen YC, Wang Y, Li JY, Xu WR, Zhang YL, (2006) H. pylori stimulates proliferation of gastric cancer cells through activating mitogen-activated protein kinase cascade. World J Gastroenterol 12: 5972-5977.
45. Robinson DR, Wu YM, Lin SF, (2000) The protein tyrosine kinase family of the human genome. Oncogene 19: 5548-5557.
46. Porter J, (2010) Small molecule c-Met kinase inhibitors: a review of recent patents. Expert Opin Ther Pat 20: 159-177.
47. Chan RJ, Feng GS, (2007) PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase. Blood 109: 862-867.
48. Goto Y, Ando T, Yamamoto K, Tamakoshi A, El-Omar E, et al. (2006) Association between serum pepsinogens and polymorphismof PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese. Int J Cancer 118: 203-208.
49. Mimuro H, Suzuki T, Tanaka J, Asahi M, Haas R, et al. (2002) Grb2 is a key mediator of helicobacter pylori CagA protein activities. Mol Cell 10: 745-755.
50. Herynk MH, Zhang J, Parikh NU, Gallick GE, (2007) Activation of Src by c-Met overexpression mediates metastatic properties of colorectal carcinoma cells. J Exp Ther Oncol 6: 205-217.